These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6100315)

  • 1. The epidemic of acquired immunodeficiency syndrome (AIDS) and suggestions for its control in drug abusers.
    Marmor M; Des Jarlais DC; Friedman SR; Lyden M; el-Sadr W
    J Subst Abuse Treat; 1984; 1(4):237-47. PubMed ID: 6100315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous drug abusers and the acquired immunodeficiency syndrome (AIDS). Demographic, drug use, and needle-sharing patterns.
    Friedland GH; Harris C; Butkus-Small C; Shine D; Moll B; Darrow W; Klein RS
    Arch Intern Med; 1985 Aug; 145(8):1413-7. PubMed ID: 3875327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection among intravenous drug users: epidemiology and risk reduction.
    Des Jarlais DC; Friedman SR
    AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Needle sharing among intravenous drug abusers: future directions.
    Battjes RJ; Pickens RW
    NIDA Res Monogr; 1988; 80():176-83. PubMed ID: 3136342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practices reported by incarcerated drug abusers to reduce risk of AIDS.
    Valdiserri EV; Hartl AJ; Chambliss CA
    Hosp Community Psychiatry; 1988 Sep; 39(9):966-72. PubMed ID: 3215646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acquired immunodeficiency syndrome and intravenous drug abuse.
    Battjes RJ; Leukefeld CG; Pickens RW; Haverkos HW
    Bull Narc; 1988; 40(1):21-34. PubMed ID: 3064841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous drug users and the acquired immune deficiency syndrome.
    Ginzburg HM
    Public Health Rep; 1984; 99(2):206-12. PubMed ID: 6424170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.
    Des Jarlais DC; Friedman SR; Hopkins W
    Ann Intern Med; 1985 Nov; 103(5):755-9. PubMed ID: 4051350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS and addiction in New York City.
    Drucker E
    Am J Drug Alcohol Abuse; 1986; 12(1-2):165-81. PubMed ID: 3641524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged incubation period of AIDS in intravenous drug abusers: epidemiological evidence in prison inmates.
    Hanrahan JP; Wormser GP; Reilly AA; Maguire BH; Gavis G; Morse DL
    J Infect Dis; 1984 Aug; 150(2):263-6. PubMed ID: 6332154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health education and knowledge assessment of HTLV-III diseases among intravenous drug users.
    Ginzburg HM; French J; Jackson J; Hartsock PI; MacDonald MG; Weiss SH
    Health Educ Q; 1986; 13(4):373-82. PubMed ID: 3781861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and intravenous drug use.
    Des Jarlais DC; Friedman SR
    AIDS; 1988; 2 Suppl 1():S65-9. PubMed ID: 3147682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge about AIDS and high-risk behavior among intravenous drug users in New York City.
    Selwyn PA; Feiner C; Cox CP; Lipshutz C; Cohen RL
    AIDS; 1987 Dec; 1(4):247-54. PubMed ID: 3126773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS health education for intravenous drug users.
    Friedman SR; Des Jarlais DC; Sotheran JL
    Health Educ Q; 1986; 13(4):383-93. PubMed ID: 3781862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS: a challenge for the public health.
    Acheson ED
    Lancet; 1986 Mar; 1(8482):662-6. PubMed ID: 2869356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987.
    Des Jarlais DC; Friedman SR; Novick DM; Sotheran JL; Thomas P; Yancovitz SR; Mildvan D; Weber J; Kreek MJ; Maslansky R
    JAMA; 1989 Feb; 261(7):1008-12. PubMed ID: 2915408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for control and prevention of human immunodeficiency virus (HIV) infection in intravenous drug users.
    Brickner PW; Torres RA; Barnes M; Newman RG; Des Jarlais DC; Whalen DP; Rogers DE
    Ann Intern Med; 1989 May; 110(10):833-7. PubMed ID: 2653157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention.
    Des Jarlais DC; Friedman SR; Stoneburner RL
    Rev Infect Dis; 1988; 10(1):151-8. PubMed ID: 3281219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus (HIV) seropositivity in intravenous (i.v.) drug abusers in three cities of Italy: possible natural history of HIV infection in i.v. drug addicts in Italy.
    Titti F; Lazzarin A; Costigliola P; Oliva C; Nicoletti L; Negri C; Ricchi E; Donati G; Uberti-Foppa C; Re MC
    J Med Virol; 1987 Nov; 23(3):241-8. PubMed ID: 3430144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.